Pychedelics
WWe are thrilled to have launched a new journal exclusively dedicated to this extraordinary field, which is experiencing a renaissance: Psychedelics: The Journal of Psychedelic Pharmacology. Why start this new journal now and why is it needed? Advances in psychedelic research are making hallucinogen substances a new frontier in psychopharmacology. As the world experiences a mental health crisis and an addiction epidemic, there is an increasing need for innovative treatments in psychiatry. Psychedelics need to be given increased attention as a therapeutic strategy. How do they work at the most fundamental molecular levels? Can pathways elucidated through the actions of psychedelics become conceptually novel new avenues for psychiatric treatment? Our new journal will bring together scientists from multiple disciplines to advance psychiatry through innovation. We will set new directions in mental health, neurology, neuroscience, therapeutics, and human consciousness. Please join us in this unprecedented journey towards discovery and its translation into highly innovative treatments.
Charles L. Raison: Elucidating the role of conscious experience in the therapeutic effects of psychedelics as a means to optimize clinical outcomes
Author: Charles L. Raison
Charles Raison, MD, is a Professor of Human Ecology and Psychiatry in the Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison. Dr. Raison also serves as Director of Clinical and Translational Research for Usona Institute, as Director of the Vail Health Behavioral Health Innovation Center, Director of Research on Spiritual Health for Emory Healthcare, and as Visiting Professor in the Center for the Study of Human Health at Emory University in Atlanta, GA. Dr. Raison's research focuses on the examination of novel mechanisms involved in the development and treatment of major depression and other stress-related emotional
DOI: https://doi.org/10.61373/pp024k.0010
Online Publication Date: 08 Mar 2024
Bernard Lerer: Pre-clinical, translational and clinical research focused on the use of psychedelic drugs and their derivatives to treat psychiatric disorders
Author: Bernard Lerer
Professor Bernard Lerer is in the Faculty of Medicine, Hebrew University, Jerusalem, Israel, where he is Director the Center for Psychedelic Research (https://cfpr.brainlabs.org.il/) at Hadassah Medical Center, in Jerusalem. The Center has a growing staff that includes senior scientists, post-docs, Ph.D. and graduate students, technicians, and psychiatrists undergoing research training. Their research is preclinical, translational, and clinical and focuses on the use of psychedelic drugs and their derivatives to treat psychiatric disorders. Previously, he was Head of the Biological Psychiatry Unit at Hadassah Medical Center for 30 years, with research and clinical responsibilities. A conversation with Professor Lerer
DOI: https://doi.org/10.61373/pp024k.0004
Katarina Leão: Links between the auditory and limbic systems, with a focus on the effects of unconventional novel treatment options, such as psychedelics and cannabis extract
Author: Katarina Leão
Katarina E. Leão, PhD, is an associate professor at the Brain Institute at the Federal University of Rio Grande do Norte, Natal, Brazil. She is vice-coordinator of the postgraduate program in neuroscience (2013–2017 and 2023 – current) and spent 2020 as a visiting professor at the Karolinska Institute/Uppsala University, Sweden. She is head of the Hearing and Neuronal activity lab researching neuronal mechanisms of noise-induced tinnitus and tinnitus-related anxiety. Dr. Leão recently joined the ongoing interview series by Genomic Press, discussing her professional endeavors and personal experiences.
DOI: https://doi.org/10.61373/pp024k.0001
Online Publication Date: 25 Jan 2024
Psychedelics: The Journal of Psychedelic Pharmacology – Charting a new course in psychedelic science
Author: Julio Licinio
Welcome home! It is with great pleasure that we present to you the first editorial of “Psychedelics: The Journal of Psychedelic Pharmacology.” This is a labor of love and intellect designed to encapsulate the swirling cascades of research discovery in psychedelics. At a moment when empirical investigation has begun to lift the haze surrounding these extraordinary compounds, this journal will rapidly become the fulcrum for scholarly conversation, discourse, and enlightenment. Our ambit is broad in its sweep, ensconcing the multidisciplinary essence of the research in question.
Our endeavor encompasses a dazzling array of inquiries, from the microscopic facets
DOI: https://doi.org/10.61373/pp024d.0007
Online Publication Date: 25 Jan 2024
